Search

everythinglearnresearchcommunity

for

Search:↓

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Chicken feather gene mutation helps understand human hair disorders.

Higher minoxidil dose helps hair growth in non-responders without side effects.

Sweat glands and hair follicles are determined by opposing signals, with BMPs promoting sweat glands and blocking BMPs leading to hair follicles.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Propylthiouracil can cause hair loss, reduced sweating, and nail issues, but stopping the drug can reverse hair and nail problems.

The vitreous membrane in hair follicles changes shape during the hair cycle and may affect hair growth and nutrient exchange.

miR-486 may help prevent hair loss in alopecia areata.